Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224069373> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W4224069373 abstract "Abstract Background Inflammatory bowel disease (IBD), a disease that seriously harms human and animal health, has attracted many researchers' attention because of its complexity and difficulty in treatment. Most research has involved rats and dogs, and very little was cats. We should know that gut microbiota varies significantly from animal to animal. Traditional Chinese Medicine and its monomer component have many advantages compared with antibiotics used in pet clinics. Numerous studies have shown berberine (berberine hydrochloride， BBr) therapeutic value for IBD; however, the specific mechanism remains to consider.Results We assessed gut pathology and analyzed fecal bacterial composition using Histological staining and 16S rRNA sequence. DSS administration destroyed intestinal mucosal structure and changed the diversity of intestinal flora relative to control. RT-PCR and western blot confirmed specific molecular mechanisms that trigger acute inflammation and intestinal mucosal barrier function disruption after DSS treatment. And autophagy inhibition is typical pathogenesis of IBD. Interestingly, berberine ameliorates inflammation during the development of the intestinal by modulating the TLR4(Toll-like receptors 4)/NF-κB signaling pathway and activating autophagy. Berberine significantly reduces tumor necrosis factor α(TNF-α), interleukin (IL)-6, and IL-1β expression in cats' serum. Enhancing the antioxidant effect of IBD cats is one of the protective mechanisms of berberine. We demonstrated that berberine repairs intestinal barrier function by activating the mTOR(mammalian target of rapamycin) complex, which inhibits autophagy.Conclusions Berberine can restore intestinal microbiota homeostasis and regulate the TLR4/ NF-Κb pathway, thereby controlling inflammatory responses. In addition, we propose a novel mechanism of berberine therapy for IBD, namely, berberine therapy can simultaneously activate MTORC and autophagy to restore intestinal mucosal barrier function in cats, which should be further studied to shed light on berberine to IBD." @default.
- W4224069373 created "2022-04-19" @default.
- W4224069373 creator A5032351846 @default.
- W4224069373 creator A5038063045 @default.
- W4224069373 creator A5057034236 @default.
- W4224069373 creator A5088888341 @default.
- W4224069373 date "2022-04-13" @default.
- W4224069373 modified "2023-09-29" @default.
- W4224069373 title "Berberine maintains intestinal homeostasis through modulating TLR4/ NF-κB / MTORC pathway and autophagy in cats" @default.
- W4224069373 doi "https://doi.org/10.21203/rs.3.rs-1537283/v1" @default.
- W4224069373 hasPublicationYear "2022" @default.
- W4224069373 type Work @default.
- W4224069373 citedByCount "1" @default.
- W4224069373 countsByYear W42240693732022 @default.
- W4224069373 crossrefType "posted-content" @default.
- W4224069373 hasAuthorship W4224069373A5032351846 @default.
- W4224069373 hasAuthorship W4224069373A5038063045 @default.
- W4224069373 hasAuthorship W4224069373A5057034236 @default.
- W4224069373 hasAuthorship W4224069373A5088888341 @default.
- W4224069373 hasBestOaLocation W42240693731 @default.
- W4224069373 hasConcept C126322002 @default.
- W4224069373 hasConcept C17991360 @default.
- W4224069373 hasConcept C190283241 @default.
- W4224069373 hasConcept C203014093 @default.
- W4224069373 hasConcept C203522944 @default.
- W4224069373 hasConcept C2776070231 @default.
- W4224069373 hasConcept C2776914184 @default.
- W4224069373 hasConcept C2778260677 @default.
- W4224069373 hasConcept C2779134260 @default.
- W4224069373 hasConcept C2780116568 @default.
- W4224069373 hasConcept C539455810 @default.
- W4224069373 hasConcept C55493867 @default.
- W4224069373 hasConcept C62478195 @default.
- W4224069373 hasConcept C71924100 @default.
- W4224069373 hasConcept C86554907 @default.
- W4224069373 hasConcept C86803240 @default.
- W4224069373 hasConcept C95444343 @default.
- W4224069373 hasConcept C98274493 @default.
- W4224069373 hasConceptScore W4224069373C126322002 @default.
- W4224069373 hasConceptScore W4224069373C17991360 @default.
- W4224069373 hasConceptScore W4224069373C190283241 @default.
- W4224069373 hasConceptScore W4224069373C203014093 @default.
- W4224069373 hasConceptScore W4224069373C203522944 @default.
- W4224069373 hasConceptScore W4224069373C2776070231 @default.
- W4224069373 hasConceptScore W4224069373C2776914184 @default.
- W4224069373 hasConceptScore W4224069373C2778260677 @default.
- W4224069373 hasConceptScore W4224069373C2779134260 @default.
- W4224069373 hasConceptScore W4224069373C2780116568 @default.
- W4224069373 hasConceptScore W4224069373C539455810 @default.
- W4224069373 hasConceptScore W4224069373C55493867 @default.
- W4224069373 hasConceptScore W4224069373C62478195 @default.
- W4224069373 hasConceptScore W4224069373C71924100 @default.
- W4224069373 hasConceptScore W4224069373C86554907 @default.
- W4224069373 hasConceptScore W4224069373C86803240 @default.
- W4224069373 hasConceptScore W4224069373C95444343 @default.
- W4224069373 hasConceptScore W4224069373C98274493 @default.
- W4224069373 hasLocation W42240693731 @default.
- W4224069373 hasOpenAccess W4224069373 @default.
- W4224069373 hasPrimaryLocation W42240693731 @default.
- W4224069373 hasRelatedWork W2095292882 @default.
- W4224069373 hasRelatedWork W2162633875 @default.
- W4224069373 hasRelatedWork W2328896170 @default.
- W4224069373 hasRelatedWork W2514386754 @default.
- W4224069373 hasRelatedWork W2539340130 @default.
- W4224069373 hasRelatedWork W2735568802 @default.
- W4224069373 hasRelatedWork W2956395590 @default.
- W4224069373 hasRelatedWork W3015790888 @default.
- W4224069373 hasRelatedWork W4245133104 @default.
- W4224069373 hasRelatedWork W4286212700 @default.
- W4224069373 isParatext "false" @default.
- W4224069373 isRetracted "false" @default.
- W4224069373 workType "article" @default.